BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) 

75 Sidney Street, 4th Floor

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-299-5000 Fax: 617-995-4995


SEARCH JOBS

View Clinical Trials from BioPharm Insight



 Key Statistics


Email: info@aveopharma.com
Ownership: Public

Web Site: AVEO Oncology
Employees:
Symbol: AVEO
 





Collaborations

Merck & Co.  Cancer





 Company News
AVEO Oncology (AVEO) Announces Presentation Of Final Results Of Extension Study 902 And FDA Regulatory Feedback For Advancing Tivozanib In Renal Cell Carcinoma 5/20/2015 12:29:20 PM
AVEO Oncology (AVEO) Announces Presentation Of Final Results Of Extension Study 902 And FDA Regulatory Feedback For Advancing Tivozanib In Renal Cell Carcinoma 5/20/2015 8:10:47 AM
AVEO Oncology (AVEO) Reports First Quarter 2015 Financial Results 5/7/2015 12:49:10 PM
AVEO Oncology (AVEO) Names Keith S. Ehrlich As Chief Financial Officer 4/22/2015 11:01:58 AM
AVEO Oncology (AVEO) Announces Presentation Of AV-380 Preclinical Data In Cancer Associated Cachexia At 2015 Annual Meeting Of The AACR 4/20/2015 11:20:58 AM
AVEO Oncology (AVEO) Announces Presentation Of Phase 2 Study Analysis Showing Longer PFS With Tivozanib Compared To Bevacizumab In Low Serum NRP-1 Patients With Advanced CRC 3/6/2015 10:42:02 AM
AVEO Oncology (AVEO) Reports Full Year 2014 Financial Results 3/6/2015 7:49:53 AM
AVEO Oncology (AVEO) To Host Conference Call To Discuss Presentation Of Final Results And Biomarker Analysis From Phase 2 Study Of Tivozanib In Patients With Advanced Colorectal Cancer 2/27/2015 10:53:27 AM
AVEO Oncology (AVEO) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/12/2015 10:25:03 AM
AVEO Oncology (AVEO) Names Michael N. Needle, M.D., As Chief Medical Officer 1/9/2015 9:42:52 AM
12345678910...